1. Business Introduction Business is a highly profitable aesthetic clinic platform dominating Thailands "Medium-to-High-End" market with a 13-year track record of clinical excellence. The business operates 8 branches in Bangkoks highest-traffic commercial zones, specializing in high-demand, non-invasive procedures like Botox and Fillers. The clinic perfectly aligns with Thailand's booming aesthetic market (projected 11.6% CAGR through 2030). The founder is seeking a full exit to focus entirely on personal ventures, presenting a rare opportunity for a strategic buyer to acquire a proven, systematized platform ready for immediate national scaling. 2. Transaction Overview - Operating Assets 8 fully-fitted leasehold branches in strategic locations and all necessary regulatory/clinical licenses valid through 2028. - Brand Intangible Assets Established brand with "Top Filler" national awards and a 13-year proprietary customer database. - Human Capital Continuity Employs 50+ trained staff and 11 specialized rotating doctors. The business operates on a Founder-Independent Model with Zero Keyman Risk. - Handover Period The founder commits to a structured 12-month transition period (6 months on-site, 6 months remote) to ensure a full transfer of operational and procurement expertise. 3. Key Highlights - Strategic Margin Procurement Advantage The business maintains highly competitive gross margins of 4854%. Being a Top 20 national purchaser for global aesthetic suppliers creates a significant procurement "moat," ensuring preferential pricing and early access to innovations. - Local Market Dominance 95% of total revenue is generated from Thai residents (office professionals and suburban families). This local-heavy split acts as a macroeconomic hedge, insulating the business from the volatility of international medical tourism. - Proven Scale-Up Playbook Financials Delivered a robust 21.5% Revenue CAGR (20222025) while scaling from 5 to 8 locations. The business utilizes an "asset-light" chassis with a lean setup cost of THB 5 Million per site, allowing for rapid, low-CAPEX expansion. In 2025, it generated THB 51.5 Million in Gross Profit and a strong Adjusted EBITDA of THB 23.3 Million.